Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Snowballgrowthon Apr 19, 2019 11:39am

79 Views

Post# 29648929

RE:RE:Votes with J. Goodman

TheRock077 wrote: Goodman must first resolve his ethical conflicts, especially his larger ownership of Pharamascience.

He will be forced to make a choice , either Knight wholly or Pharmacience.

There is also the sookish part of Goodman who states that he cannot work with anyone else who is his equal plus the fact that he wont have his current crony BOD.

Meir is now holding most of the cards.

I would love to see a renewed JV between Medison and Knight which would finally enable the large potential for accretive benefits to each.

The absence of a retort from Goodman tells me that some negottiations might be underway.

If so, great.